BSE filing, NSE: WELINV. Summary written from the filing by ALFA Finder's alert engine.
Welspun Investments & Commercials Ltd: key numbers
- Share price
- ₹1,977.10
- Market cap
- ₹722.5 Cr
- Revenue (annual)
- ₹5.20 Cr
- Net profit (annual)
- ₹3.03 Cr
- P/E (TTM)
- 234.3×Sector 19.7×
- Promoter holding
- 74.58%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Welspun Investments & Commercials Ltd
All →Welspun Investments & Commercials Q2 FY27 Results: Net Profit ₹8.8 Cr, Up 151.4% YoY
Welspun Investments & Commercials Ltd reported revenue from operations of ₹14.1 Cr (+187.8% YoY) and net profit of ₹8.8 Cr (+151.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.8 Cr · +151.4% YoY
Welspun Investments & Commercials Board Meeting Date
Welspun Investments and Commercials will hold a board meeting on 28 October 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from 1 October to 30 October 2026.
Welspun Investments & Commercials Annual General Meeting
Welspun Investments and Commercials Limited held its 18th Annual General Meeting on September 30, 2026, where shareholders approved financial statements, director appointment, and a related party investment.
Welspun Investments & Commercials Annual General Meeting
Welspun Investments and Commercials Limited announced book closure from September 16 to September 18, 2026. This closure is for the purpose of the Annual General Meeting.
Welspun Investments & Commercials Board Meeting Outcome
Welspun Investments and Commercials' board approved a ₹1,285 crore infusion into a wholly owned subsidiary and a ₹1,000 crore investment by that subsidiary into a promoter group company.
- Value
- ₹2,285 Cr
Welspun Investments & Commercials Acquisition
Welspun Investments and Commercials Ltd has completed its acquisition of a 100% stake in Vishwakarma Realty Private Limited. VRPL is now a wholly-owned subsidiary.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.